Charles Rivera: Unscripted

With a fresh $50M, Patronus AI is moving beyond static tests, building simulated worlds where AI agents can learn, fail, and improve safely.

Former Congressman Derek Kilmer joins BAE's board, bringing deep government insight. Is it a masterstroke of strategy or another turn of the 'revolving door'?

As deepfakes threaten enterprise security, a new partnership between Scam.ai and Qualcomm moves the battle from the cloud to your device, promising a more private future.

A new tech partnership promises to slash gun crime investigation times from weeks to hours, but what does this new era of connected policing mean for our future?

Triple Flag's US$440M gold stream on Australia's Ravenswood mine is more than a deal. It's a look into the future of mining finance and strategic investment.

AgileAI Labs' new tool lets non-coders test software in plain English, aiming to finally bridge the costly gap between human ideas and flawless code.

The Pestera II wind farm isn't just an energy project; it's a blueprint for attracting global capital and accelerating a national green transition.

As U.S. manufacturers race to modernize, a new report reveals a dangerous gap between innovation and security, turning consumer trust into a new battleground.

A curious cat, two discarded sliders, and a near-fatal poisoning. Roamin's story reveals the unseen dangers in our homes and the experts who save lives.

American Beacon and Aberdeen deepen their alliance with a new ETF, aiming to deliver tax-free income by actively navigating the complex municipal bond market.

International runners are turning Japan's marathons into extended family holidays, blending sport with cultural exploration and boosting local economies.

A novel drug for glioblastoma enters a revolutionary trial, but the real story is the mission-driven company behind it, rewriting the rules of drug development.

With M&A veterans Martin Babler and Troy Cox joining its board, MapLight Therapeutics is signaling a strategic shift from foundational research to late-stage execution.

Main Street Capital's $46.4M gain from Centre Technologies is more than a headline. It’s a masterclass in strategic partnership and lower middle market investment.

AM Best's 'Excellent' rating affirms Allshores' post-merger strength, but a closer look reveals a strategic battle against rising healthcare costs and climate risk.

A new digital portal and landmark law signal a pivotal shift in Saudi Arabia's Vision 2030, aiming to transform its economy beyond oil.

Avee Health’s milestone is a win for access, but it also signals a profound shift in public healthcare. We look at the why behind the virtual care boom.

A looming United Healthcare reimbursement change threatens to destabilize lactation care, leaving providers and new parents in a precarious position.

Clarevia Ventures' new partner isn't just another investor. She's a top analyst tasked with a critical mission: bridging the gap between science and patient impact.

A massive new solar and battery plant in rural Utah isn't just generating power; it's a blueprint for community investment and energy independence.